Graham Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Buy |
71,620
+34,003
| +90% | +$477K | 0.02% | 541 |
|
|
2025
Q1 | $588K | Buy |
37,617
+10,780
| +40% | +$169K | 0.01% | 710 |
|
|
2024
Q4 | $374K | Buy |
26,837
+4,551
| +20% | +$63.4K | 0.01% | 815 |
|
|
2024
Q3 | $207K | Sell |
22,286
-43,879
| -66% | -$408K | ﹤0.01% | 868 |
|
|
2024
Q2 | $615K | Buy |
66,165
+52,699
| +391% | +$490K | 0.01% | 495 |
|
|
2024
Q1 | $133K | Sell |
13,466
-48,951
| -78% | -$485K | ﹤0.01% | 922 |
|
|
2023
Q4 | $202K | Buy |
+62,417
| New | +$202K | ﹤0.01% | 816 |
|